Adam Conley

1.1k total citations
9 papers, 810 citations indexed

About

Adam Conley is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Adam Conley has authored 9 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in Adam Conley's work include Phosphodiesterase function and regulation (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Adam Conley is often cited by papers focused on Phosphodiesterase function and regulation (3 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Adam Conley collaborates with scholars based in United States and Canada. Adam Conley's co-authors include Carl A. Gregory, Darwin J. Prockop, William Gunn, Scott D. Olson, Lisa Deininger, Nichola Cruickshanks, Andrew Poklepovic, Paul Dent, Jane L. Roberts and Laurence Booth and has published in prestigious journals such as Journal of Biological Chemistry, The Lancet Neurology and Stem Cells.

In The Last Decade

Adam Conley

9 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Conley United States 8 273 240 234 191 187 9 810
Phillip A. Letourneau United States 10 95 0.3× 64 0.3× 82 0.4× 70 0.4× 34 0.2× 11 471
Samantha Costa United States 9 93 0.3× 48 0.2× 36 0.2× 38 0.2× 98 0.5× 22 382
Jianhua Feng China 17 222 0.8× 129 0.5× 38 0.2× 10 0.1× 153 0.8× 48 727
Orly Zelig Israel 15 172 0.6× 23 0.1× 99 0.4× 32 0.2× 53 0.3× 35 877
Laveniya Satgunaseelan Australia 14 368 1.3× 65 0.3× 303 1.3× 18 0.1× 171 0.9× 38 946
Carol Cornejo United States 13 170 0.6× 70 0.3× 24 0.1× 57 0.3× 38 0.2× 17 659
Kay Elderfield United Kingdom 11 155 0.6× 37 0.2× 81 0.3× 7 0.0× 75 0.4× 13 635
Christopher A. Bogaev United States 8 102 0.4× 138 0.6× 520 2.2× 30 0.2× 32 0.2× 10 811
Todd J. Janus United States 14 233 0.9× 31 0.1× 41 0.2× 14 0.1× 220 1.2× 25 1.1k
Kaushik Mandal United States 13 162 0.6× 26 0.1× 74 0.3× 87 0.5× 72 0.4× 22 785

Countries citing papers authored by Adam Conley

Since Specialization
Citations

This map shows the geographic impact of Adam Conley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Conley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Conley more than expected).

Fields of papers citing papers by Adam Conley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Conley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Conley. The network helps show where Adam Conley may publish in the future.

Co-authorship network of co-authors of Adam Conley

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Conley. A scholar is included among the top collaborators of Adam Conley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Conley. Adam Conley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mangano, Francesco T., Charles B. Stevenson, Usha D. Nagaraj, Adam Conley, & Weihong Yuan. (2019). Abnormal anisotropic diffusion properties in pediatric myelomeningocele patients treated with fetal surgery: an initial DTI study. Child s Nervous System. 36(4). 827–833. 7 indexed citations
2.
Roberts, Jane L., Laurence Booth, Adam Conley, et al.. (2014). PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells. Cancer Biology & Therapy. 15(6). 758–767. 44 indexed citations
3.
Booth, Laurence, Jane L. Roberts, Nichola Cruickshanks, et al.. (2014). PDE5 Inhibitors Enhance Celecoxib Killing in Multiple Tumor Types. Journal of Cellular Physiology. 230(5). 1115–1127. 46 indexed citations
4.
Booth, Laurence, Jane L. Roberts, Adam Conley, et al.. (2013). HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cells. Cancer Biology & Therapy. 15(3). 305–316. 33 indexed citations
5.
Booth, Laurence, Jane L. Roberts, Nichola Cruickshanks, et al.. (2013). Phosphodiesterase 5 Inhibitors Enhance Chemotherapy Killing in Gastrointestinal/Genitourinary Cancer Cells. Molecular Pharmacology. 85(3). 408–419. 62 indexed citations
6.
Conley, Adam, Brian Cho, Gary Tye, et al.. (2013). Giant cell reparative granuloma of the pediatric cranium: case report and review of the literature. Child s Nervous System. 30(3). 521–526. 4 indexed citations
7.
Clifton, Guy L., Alex B. Valadka, David Zygun, et al.. (2010). Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. The Lancet Neurology. 10(2). 131–139. 322 indexed citations
9.
Gregory, Carl A., Anthony S. Perry, Emigdio D. Reyes, et al.. (2004). Dkk-1-derived Synthetic Peptides and Lithium Chloride for the Control and Recovery of Adult Stem Cells from Bone Marrow. Journal of Biological Chemistry. 280(3). 2309–2323. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026